Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,626 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction.
Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Nishida T, Morikawa Y, Nakagawa H, Tsutsumi T, Sung JH, Takemoto Y, Soeda T, Okayama S, Ishigami K, Kawata H, Horii M, Nakajima T, Saito Y. Onoue K, et al. Among authors: takeda y. Am J Cardiol. 2009 Dec 1;104(11):1478-83. doi: 10.1016/j.amjcard.2009.07.016. Am J Cardiol. 2009. PMID: 19932778
Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction.
Iwama H, Uemura S, Naya N, Imagawa K, Takemoto Y, Asai O, Onoue K, Okayama S, Somekawa S, Kida Y, Takeda Y, Nakatani K, Takaoka M, Kawata H, Horii M, Nakajima T, Doi N, Saito Y. Iwama H, et al. Among authors: takeda y. J Am Coll Cardiol. 2006 Apr 18;47(8):1559-67. doi: 10.1016/j.jacc.2005.11.064. Epub 2006 Mar 27. J Am Coll Cardiol. 2006. PMID: 16630991 Free article.
Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
Horii M, Uemura S, Uemura M, Matsumoto M, Ishizashi H, Imagawa K, Iwama H, Takeda Y, Kawata H, Nakajima T, Fujimura Y, Saito Y. Horii M, et al. Among authors: takeda y. Heart Vessels. 2008 Sep;23(5):301-7. doi: 10.1007/s00380-008-1053-x. Epub 2008 Sep 20. Heart Vessels. 2008. PMID: 18810578
Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction.
Takeda Y, Uemura S, Iwama H, Imagawa K, Nishida T, Onoue K, Takemoto Y, Soeda T, Okayama S, Somekawa S, Ishigami K, Takaoka M, Kawata H, Kubo A, Horii M, Nakajima T, Saito Y. Takeda Y, et al. Circ J. 2009 Sep;73(9):1674-82. doi: 10.1253/circj.cj-08-1067. Epub 2009 Jul 15. Circ J. 2009. PMID: 19602778 Free article.
Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.
Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Imagawa K, Nishida T, Morikawa Y, Takemoto Y, Asai O, Soeda T, Okayama S, Ishigami K, Nakatani K, Kawata H, Horii M, Nakajima T, Akai Y, Iwano M, Saito Y. Onoue K, et al. Among authors: takeda y. Circulation. 2009 Dec 15;120(24):2470-7. doi: 10.1161/CIRCULATIONAHA.109.867929. Circulation. 2009. PMID: 19948974
Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
Horii M, Matsumoto T, Uemura S, Sugawara Y, Takitsume A, Ueda T, Nakagawa H, Nishida T, Soeda T, Okayama S, Somekawa S, Ishigami K, Takeda Y, Kawata H, Kawakami R, Saito Y. Horii M, et al. Among authors: takeda y. J Cardiol. 2013 Jun;61(6):410-6. doi: 10.1016/j.jjcc.2013.01.015. Epub 2013 Apr 22. J Cardiol. 2013. PMID: 23618914 Free article.
An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
Matsumoto T, Uemura S, Takeda Y, Matsui M, Okada S, Nishida T, Soeda T, Okayama S, Somekawa S, Ishigami K, Onoue K, Kawata H, Kawakami R, Horii M, Saito Y. Matsumoto T, et al. Among authors: takeda y. Intern Med. 2013;52(10):1019-27. doi: 10.2169/internalmedicine.52.9073. Epub 2013 May 15. Intern Med. 2013. PMID: 23676585 Free article. Clinical Trial.
Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease.
Matsui M, Takeda Y, Uemura S, Matsumoto T, Seno A, Onoue K, Tsushima H, Morimoto K, Soeda T, Okayama S, Somekawa S, Samejima K, Kawata H, Kawakami R, Nakatani K, Iwano M, Saito Y. Matsui M, et al. Among authors: takeda y. Kidney Int. 2014 Feb;85(2):393-403. doi: 10.1038/ki.2013.339. Epub 2013 Sep 18. Kidney Int. 2014. PMID: 24048373 Free article.
Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
Ueda T, Kawakami R, Sugawara Y, Okada S, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y. Ueda T, et al. Among authors: takeda y. J Am Heart Assoc. 2014 Nov 4;3(6):e001174. doi: 10.1161/JAHA.114.001174. J Am Heart Assoc. 2014. PMID: 25370599 Free PMC article.
4,626 results